W. Mehnert

10.6k total citations · 3 hit papers
58 papers, 8.3k citations indexed

About

W. Mehnert is a scholar working on Pharmaceutical Science, Molecular Biology and Organic Chemistry. According to data from OpenAlex, W. Mehnert has authored 58 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pharmaceutical Science, 29 papers in Molecular Biology and 12 papers in Organic Chemistry. Recurrent topics in W. Mehnert's work include Advancements in Transdermal Drug Delivery (26 papers), Lipid Membrane Structure and Behavior (22 papers) and Dermatology and Skin Diseases (10 papers). W. Mehnert is often cited by papers focused on Advancements in Transdermal Drug Delivery (26 papers), Lipid Membrane Structure and Behavior (22 papers) and Dermatology and Skin Diseases (10 papers). W. Mehnert collaborates with scholars based in Germany and Italy. W. Mehnert's co-authors include Karsten Mäder, A. zur Mühlen, Monika Schäfer‐Korting, Rainer Müller, Hans Christian Körting, Eliana B. Souto, R.H. Müller, K.D. Kramer, Heike Bunjes and Christoph Johann and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

W. Mehnert

58 papers receiving 7.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Solid lipid nanoparticles Production, characterization and applications

2001 2.5k citations W. Mehnert Advanced Drug Delivery Reviews profile →
Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism

1998 747 citations A. zur Mühlen, W. Mehnert et al. European Journal of Pharmaceutics and Biopharmaceutics profile →
Solid lipid nanoparticles

2012 680 citations W. Mehnert, Karsten Mäder Advanced Drug Delivery Reviews profile →

Peers

Countries citing papers authored by W. Mehnert

Since Specialization

Citations

This map shows the geographic impact of W. Mehnert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Mehnert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Mehnert more than expected).

Fields of papers citing papers by W. Mehnert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Mehnert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Mehnert. The network helps show where W. Mehnert may publish in the future.

Co-authorship network of co-authors of W. Mehnert

This figure shows the co-authorship network connecting the top 25 collaborators of W. Mehnert. A scholar is included among the top collaborators of W. Mehnert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Mehnert. W. Mehnert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improving Topical Non-Melanoma Skin Cancer Treatment: In vitro Efficacy of a Novel Guanosine-Analog Phosphonate 2014 ·Skin Pharmacology and Physiology ·C. Laue, Christian Zoschke, (unknown), (unknown), (unknown), W. Mehnert, Tobias Blaschke, K.D. Kramer, Johanna Plendl, Günther Weindl, H.C. Korting, (unknown), Hans F. Merk, Monika Schäfer‐Korting	8
2	Drug Release and Skin Penetration from Solid Lipid Nanoparticles and a Base Cream: A Systematic Approach from a Comparison of Three Glucocorticoids 2011 ·Skin Pharmacology and Physiology ·Peggy Schlupp, Tobias Blaschke, K.D. Kramer, H.‐D. Höltje, W. Mehnert, Monika Schäfer‐Korting	63
3	Interaction of drug molecules with carrier systems as studied by parelectric spectroscopy and electron spin resonance 2007 ·Journal of Controlled Release ·(unknown), Tobias Blaschke, (unknown), W.M. Herrmann, Peggy Schlupp, (unknown), (unknown), W. Mehnert, Robert Bittl, Monika Schäfer‐Korting, K.D. Kramer	33
4	In vitro skin absorption and drug release – A comparison of six commercial prednicarbate preparations for topical use 2007 ·European Journal of Pharmaceutics and Biopharmaceutics ·S. Lombardi Borgia, Peggy Schlupp, W. Mehnert, Monika Schäfer‐Korting	46
5	Lipid nanoparticles for improved topical application of drugs for skin diseases☆ 2007 ·Advanced Drug Delivery Reviews ·Monika Schäfer‐Korting, W. Mehnert, Hans Christian Körting	471
6	Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals 2006 ·International Journal of Pharmaceutics ·Rainer Müller, (unknown), Vitale Ravelli, W. Mehnert, Andreas F. Thünemann, Eliana B. Souto	249
7	Polymorphic behaviour of Compritol®888 ATO as bulk lipid and as SLN and NLC 2006 ·Journal of Microencapsulation ·Eliana B. Souto, W. Mehnert, Rainer Müller	174
8	Solid Lipid Nanoparticles (SLN) and Oil-Loaded SLN Studied by Spectrofluorometry and Raman Spectroscopy 2005 ·Pharmaceutical Research ·(unknown), Annekathrin Haberland, S. Wartewig, Karsten Mäder, W. Mehnert	111
9	Lipid nanoparticles for skin penetration enhancement—correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy 2005 ·Journal of Controlled Release ·S. Lombardi Borgia, (unknown), Sivaramakrishnan Rajaraman, W. Mehnert, H.C. Korting, Kerstin Danker, Beate Röder, K.D. Kramer, Monika Schäfer‐Korting	188
10	Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy 2004 ·Journal of Controlled Release ·(unknown), W. Mehnert, Markus Drechsler, Heike Bunjes, Christoph Johann, Karsten Mäder	331
11	Glucocorticoid entrapment into lipid carriers — characterisation by parelectric spectroscopy and influence on dermal uptake 2004 ·Journal of Controlled Release ·Sivaramakrishnan Rajaraman, Chié Nakamura, W. Mehnert, H.C. Korting, K.D. Kramer, Monika Schäfer‐Korting	100
12	Physicochemical Investigations on Solid Lipid Nanoparticles and on Oil-Loaded Solid Lipid Nanoparticles: A Nuclear Magnetic Resonance and Electron Spin Resonance Study 2003 ·Pharmaceutical Research ·(unknown), W. Mehnert, Karsten Mäder	140
13	Drug Targeting by Solid Lipid Nanoparticles for Dermal Use 2002 ·Journal of drug targeting ·(unknown), W. Mehnert, Martin Schaller, Hans Christian Körting, Anja Gysler, Annekathrin Haberland, Monika Schäfer‐Korting	136
14	Solid lipid nanoparticles Production, characterization and applications breakdown → 2001 ·Advanced Drug Delivery Reviews ·W. Mehnert	2490
15	Pflanzliche Begleitstoffe — wertvolle Hilfsstoffe oder überflüssiger Ballast? 2000 ·Pharmazie in unserer Zeit ·Michael Eder, W. Mehnert	6
16	Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism breakdown → 1998 ·European Journal of Pharmaceutics and Biopharmaceutics ·A. zur Mühlen, (unknown), W. Mehnert	747
17	Solid Lipid Nanoparticles - ein neuartiger Wirkstoff-Carrier für Kosmetika und Pharmazeutika 2. Mitteilung: Wirkstoff-Inkorporation, Freisetzung und Sterilisierbarkeit 1997 ·W. Mehnert, A. zur Mühlen, Aaron Dingler, (unknown), Rainer Müller	23
18	Solid Lipid Nanoparticles : ein neuartiger Wirkstoff-Carrier für Kosmetika und Pharmazeutika. 1. Mitteilung: Systemeigenschaften, Herstellung und Scaling-up 1997 ·Rainer Müller, (unknown), A. zur Mühlen, Aaron Dingler, W. Mehnert	19
19	Solid lipid nanoparticles : ein neuartiger Wirkstoff-Carrier für Kosmetika und Pharmazeutika. 3. Mitteilung: Langzeitstabilität, Gefrier- und Sprühtrocknung, Toxizität, Anwendung in Kosmetika und Pharmazeutika 1997 ·Rainer Müller, Aaron Dingler, (unknown), A. zur Mühlen, W. Mehnert	11
20	Solid lipid nanoparticles (SLN) : an alternative colloidal carrier system for controlled drug delivery 1995 ·European Journal of Pharmaceutics and Biopharmaceutics ·R.H. Müller, W. Mehnert, (unknown), (unknown), A. zur Mühlen, (unknown), Camila Fabiano de Freitas, (unknown)	375

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact